Active Surveillance Prostate Cancer Video Chat, February 11th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Ray E 8:25 PM
i know but if I just cut in I think others will to but if you prefer I will cut in
AnCan – Rick 8:39 PM
Dr. Sanoj Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775
Hugh -Houston 8:48 PM
2nd Opinions for Biopsies: -Jonathan Epstein, MD https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org) -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
AnCan – Rick 8:49 PM
Dr. Michael Liss https://providers.ucsd.edu/details/1477733012/urology-cancer
Active Surveillance Prostate Cancer Video Chat, January 14th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Phil-Toronto 8:05 PM
Prostate Cancer Journal Club for Patients tomorrow at 9:00am ” can Micro U/S replace MRI for PCa Diagnosis Matt Cooperberg Laurence Klotz meded.ucsf.edu
Martin 8:13 PM
Brian, my email is martinuthe14@gmail.com. I would love to hear about your acqua ablation. Thx!
BJ 8:24 PM
Hi guys anyone have a link for the mentioned webinar tomorrow?
Phil-Toronto 8:25 PM
meded.ucsf.edu. If you google the link it should take you to the registration for the webinar tomorrow
Phil-Toronto 8:36 PM
aquablation vs. HOLEP https://www.perplexity.ai/search/80078b6b-bae2-4382-96d6-4035a1f29ba0
BJ 8:40 PM
Dan P: You mentioned a book at the beginning. if you can put the name of it on the chat. Ty
AnCan – Rick 8:50 PM
Dr. Sanjay Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775
BJ 9:01 PM
Need to drop off. Thanks all for sharing so much.
AnCan – Rick 9:06 PM
Helfand webinar on AS on AnCan https://ancan.org/webinar-active-surveillance-beyond-with-dr-brian-helfand/
AnCan – Rick 9:13 PM
@RogerNorris…. PROSTATE, not prostrate.
Veterans and Prostate Cancer: What You Need to Know – Interview with Mike Crosby
Mike Crosby, Ancan Advisory Board Member, is a retired Navy commander and a prostate cancer survivor. Crosby is the founder of Veterans Prostate Cancer Awareness (VPCa), a nonprofit organization dedicated to educating veterans about prostate cancer screening and treatment options.
He is passionate about raising awareness about prostate cancer, particularly among veterans, and has spoken publicly about his experiences and the importance of early detection and treatment. He recently did an interview on KNTV about what veterans need to know about their increased risk of prostate cancer.
If you have a few minutes, click here or watch above.
Is It OK to Take Supplements After a Prostate Cancer Diagnosis? by Stuart Jordan
We were recently asked by a newly diagnosed member of our group—who is preparing to begin treatment—about a dietary supplement he has been taking. His question had two parts: Could this supplement help with prostate cancer? And just as important, is it safe to keep taking it now?
It’s a fair question, and a very common one. Many supplements are marketed as supportive of prostate health, metabolism, or weight management, and it’s easy to assume they might be helpful during cancer treatment.
In my day job as publisher of the Wellness Letter, we often see how supplement claims outpace the science behind them. That’s why we rely on evidence-based research as the final word when exploring questions like these.
When we look closely at the research, the picture is clearer than the marketing suggests. So far, no dietary supplement has been shown in solid human studies to prevent, treat, or slow the progression of prostate cancer once diagnosed. Some supplements that once sounded promising haven’t held up in careful trials. Others affect lab markers, such as PSA, without improving outcomes that truly matter. In fact, some supplements—like high-dose vitamin E or selenium—have actually shown potential harm in trials.
Safety is just as important. Supplements and over-the-counter products can interact with medications, affect lab results, or interfere with how treatments work. This matters whether a man is on active surveillance, receiving hormone therapy, undergoing radiation therapy, or after treatment. Even products that seem harmless can complicate care if the medical team isn’t aware of them.
That’s why it’s essential to tell your doctors about every supplement and over-the-counter product you’re taking, not just prescriptions.
Instead of relying on supplements, focusing on overall health—through diet, physical activity, weight management, and addressing true deficiencies—offers a safer, better-supported path, especially when coordinated closely with your medical team.
DISCLAIMER: AnCan does not endorse Superpower or any of its products. All patients should discuss with their healthcare provider before using any of their products or any of the tests or advice in the article.
In another of the seemingly endless organizations offering premium health services, Superpower, founded in 2023, provides a fairly straightforward overview of the myriad tests and biomarkers available to Prostate Cancer patients (A Clear Guide to PCa Biomarkers). Seasoned AnCaners may find little new in here, especially those that attend or review many of the recent seminars/webcasts, but newcomers or those needing a refresher may find it helpful for further research or equipping you to be your own best advocate. The article hits many of the main tests with which we are all familiar, as well as some of the urine biomarkers (PCA3, Select MDx, ExoDX), without specifically endorsing any of them. It does touch on MRIs, but only multi-parametric, not bi-parametric MRIs, nor does it get into the trans-rectal versus trans-perineal debate. Be forewarned, there is information with which not everyone will agree (shocking, I know), but it is still a useful, albeit somewhat rudimentary tool.
